A New Look at Tobacco Risk: Revelations from Milliman’s 42M-life Mortality Study and Clinical Data Findings
This webinar was featured live April 4 and 5, 2023. Please register to view the recording.
RegisterThis webinar was featured live April 4 and 5, 2023. Please register to view the recording.
RegisterMedical Data now uncovers evidence of tobacco use in nearly 16% of hits. Are you relying on self-reporting, easily defeated cotinine tests, or speculative tools like voice analysis? Watch the recording and clear the air with reliable data drawn from prescription histories and medical billing codes.
And what about the old 200% mortality rule of thumb for smokers? Or only looking back a year or two? We’ll share insights from Milliman’s latest, 42M-life mortality study that will surprise you. For example, evidence of nicotine dependence from five or six years ago can still indicate a relative mortality of over 200%. We’ll tell you how we know and provide clinical insight into why nicotine’s mortality effect is so tenacious.
Medical directors, underwriters, actuaries, and other clinical professionals who assess health risk will benefit from an improved understanding of smoking’s surprisingly durable mortality impact
Actuary and Product Director, Medical Data
Clinical Consultant
Actuary and Product Director
This website uses cookies to provide you with an optimized experience. Refer to our privacy policy for more information regarding our use of data or click here to learn more about the cookies we use and how to disable them.